In vivo Tracking of Mesenchymal Stem Cells Labeled with a Novel Chitosan-coated Superparamagnetic Iron Oxide Nanoparticles using 3.0T MRI

다국어 초록 (Multilingual Abstract)

This study aimed to characterize and MRI track the mesenchymal stem cells labeled with chitosan-coated superparamagnetic iron oxide (Chitosan-SPIO). Chitosan-SPIO was synthesized from a mixture of FeCl2 and FeCl3. The human bone marrow derived mesenchymal stem cells (hBM-MSC) were labeled with 50 mg Fe/mL chitosan-SPIO and Resovist. The labeling efficiency was assessed by iron content, Prussian blue staining, electron microscopy and in vitro MR imaging. The labeled cells were also analyzed for cytotoxicity, phenotype and differentiation potential. Electron microscopic observations and Prussian blue staining revealed 100% of cells were labeled with iron particles. MR imaging was able to detect the labeled MSC successfully.
Chitosan-SPIO did not show any cytotoxicity up to 200 mg Fe/mL concentration. The labeled stem cells did not exhibit any significant alterations in the surface markers expression or adipo/osteo/chondrogenic differentiation potential when compared to unlabeled control cells. After contralateral injection into rabbit ischemic brain, the iron labeled stem cells were tracked by periodical in vivo MR images. The migration of cells was also confirmed by histological studies. The novel chitosan-SPIO enables to label and track MSC for in vivo MRI without cellular alteration.

참고문헌 (Reference)

1 Newcomb CD, "Timing of cord blood treatment after experimental stroke determines therapeutic efficacy" 15 : 213-223, 2006

2 Kim EH, "Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent" 289 : 328-330, 2005

3 Lee HS, "Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan" 41 : 4102-4104, 2005

4 Wang YX, "Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging" 11 : 2319-2331, 2001

5 Stauer BE, "Stem cell therapy in perspective" 107 : 929-934, 2003

6 Deans RJ, "Mesenchymal stem cells: biology and potential clinical uses" 28 : 875-884, 2000

7 Harris LA, "Magnetic nanoparticle dispersions stabilized with triblock copolymers" 15 : 1367-1377, 2003

8 Arbab AS, "Labeling of cells with ferumoxides. Protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoitic or mesenchymal stem cells" 18 : 553-559, 2005

9 Werner N, "Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury" 93 : 17-24, 2003

10 Ittrich H, "In vivo magnetic resonance imaging of iron oxide labeled arterially injected mesenchymal stem cells in kidney of rats with acute ischemic kidney injury: detection and monitoring at 3T" 25 : 1179-1191, 2007

11 Kostura L, "Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis" 17 : 513-517, 2004

12 Arbab AS, "Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI" 104 : 1217-1223, 2004

13 Cheng SL, "Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone" 134 : 277-286, 1994

14 Berry CC, "Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro" 24 : 4551-4557, 2003

15 Bulte JW, "Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides" 104 : 3410-3413, 2004

16 Mackay AM, "Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow" 4 : 415-428, 1998

17 Sinha VR, "Chitosan microspheres as a potential carrier for drugs" 274 : 1-33, 2004

18 Arbab AS, "Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging" 229 : 838-846, 2003

19 Bowen CV, "Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells" 48 : 52-61, 2002

20 Taguchi A, "Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model" 114 : 330-338, 2004